Tomohiro Ito

834 total citations
27 papers, 609 citations indexed

About

Tomohiro Ito is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Tomohiro Ito has authored 27 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 4 papers in Oncology. Recurrent topics in Tomohiro Ito's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Asthma and respiratory diseases (3 papers). Tomohiro Ito is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Asthma and respiratory diseases (3 papers). Tomohiro Ito collaborates with scholars based in Japan, Germany and United States. Tomohiro Ito's co-authors include Yuji Imaizumi, Munekazu Shigekawa, Susumu Ohya, Yuko Iwata, Yuki Katanosaka, Katsuhiko Muraki, Yukio Taniguchi, Yoshiyuki Sasaki, Takahisa Yamada and Narihito Yoshioka and has published in prestigious journals such as Circulation Research, Neuroscience and American Journal of Clinical Pathology.

In The Last Decade

Tomohiro Ito

25 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Ito Japan 7 306 188 154 135 101 27 609
S. Mark Duffy United Kingdom 17 223 0.7× 363 1.9× 353 2.3× 184 1.4× 80 0.8× 23 848
Sarabeth Graham United States 13 333 1.1× 514 2.7× 99 0.6× 49 0.4× 131 1.3× 14 992
Cheng–Hai Zhang China 12 228 0.7× 386 2.1× 104 0.7× 53 0.4× 64 0.6× 19 808
Catalin N. Topala Netherlands 11 218 0.7× 411 2.2× 56 0.4× 92 0.7× 52 0.5× 11 949
Subhashini Srivatsan United States 8 216 0.7× 215 1.1× 100 0.6× 44 0.3× 57 0.6× 13 532
Judd W. Landsberg United States 5 508 1.7× 409 2.2× 163 1.1× 420 3.1× 139 1.4× 8 959
Chee Gee See United Kingdom 11 157 0.5× 219 1.2× 62 0.4× 41 0.3× 51 0.5× 14 442
April Hawkins United States 5 524 1.7× 776 4.1× 104 0.7× 59 0.4× 228 2.3× 6 1.4k
Michael Song United States 10 119 0.4× 480 2.6× 83 0.5× 187 1.4× 42 0.4× 12 835
Otor Al‐Khalili United States 18 75 0.2× 737 3.9× 69 0.4× 214 1.6× 63 0.6× 28 904

Countries citing papers authored by Tomohiro Ito

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Ito more than expected).

Fields of papers citing papers by Tomohiro Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Ito. The network helps show where Tomohiro Ito may publish in the future.

Co-authorship network of co-authors of Tomohiro Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Ito. A scholar is included among the top collaborators of Tomohiro Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Ito. Tomohiro Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondoh, Yasuhiro, Tomohiro Ito, Hideyuki Kimura, Haikun Bao, & Masataka Kuwana. (2025). Patient characteristics and pharmacologic treatment patterns in antifibrotic-treated patients with fibrosing interstitial lung diseases: real-world results from a claims database. BMC Pulmonary Medicine. 25(1). 253–253.
2.
Inoue, Yoshikazu, Hideya Kitamura, Masaki Okamoto, et al.. (2024). The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial. Respiratory Investigation. 62(4). 589–596. 2 indexed citations
3.
Kondoh, Yasuhiro, Tomohiro Ito, Kumiko Saito, Haikun Bao, & Wataru Sakamoto. (2024). Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database. Respiratory Investigation. 62(4). 702–709. 5 indexed citations
4.
5.
6.
Ogura, Takashi, Takafumi Suda, Naohiko Inase, et al.. (2022). Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial. Respiratory Investigation. 60(6). 787–797. 4 indexed citations
7.
Mizuguchi, Hiroyuki, Tomohiro Nakano, Tomohiro Ito, et al.. (2020). Mechanism of action of pyrogallol on calcineurin-NFAT signaling. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 93(0). 1–O. 1 indexed citations
8.
Hosaka, Masayoshi, Ichiro Arai, Yoshihisa Ishiura, et al.. (2019). Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis. International Journal of Clinical Oncology. 24(11). 1385–1396. 10 indexed citations
9.
Yotsumoto, Fusanori, Kenichi Yoshikawa, Kohei Miyata, et al.. (2019). Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial Cancer. Anticancer Research. 39(8). 4581–4588. 6 indexed citations
10.
Nakamura, Motonori, et al.. (2016). Specifying a Trust Model for Academic Cloud Services. 91–99. 2 indexed citations
11.
Abe, Machiko, et al.. (2016). CHANGES IN DONORS' ISOAGGLUTININS AGAINST RECIPIENTS' RED CELLS IN MINOR OR BIDIRECTIONAL ABO-INCOMPATIBLE HEMATOPOIETIC STEM CELL TRANSPLANTATION. Japanese Journal of Transfusion and Cell Therapy. 62(6). 699–704. 3 indexed citations
12.
Ito, Tomohiro, Makoto Hamasaki, Shinji Matsumoto, et al.. (2015). p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer. American Journal of Clinical Pathology. 143(6). 830–838. 26 indexed citations
13.
Kawakami, S., Makoto Ohmoto, Susumu Itoh, et al.. (2012). Accumulation of SNAP25 in mouse gustatory and somatosensory cortices in response to food and chemical stimulation. Neuroscience. 218. 326–334. 4 indexed citations
14.
Horiguchi, Takahiko, Nobuyuki Hayashi, Tomohiro Ito, et al.. (2006). Usefulness of HFA-BDP for Adult Patients with Bronchial Asthma: Randomized Crossover Study with Fluticasone. Journal of Asthma. 43(7). 509–512. 5 indexed citations
15.
Horiguchi, Takahiko, Jun Miyazaki, Yoshio Watanabe, et al.. (2005). Usefulness of Sparfloxacin against Chlamydia pneumoniae Infection in Patients with Bronchial Asthma. Journal of International Medical Research. 33(6). 668–676. 2 indexed citations
16.
Muraki, Katsuhiko, Yuko Iwata, Yuki Katanosaka, et al.. (2003). TRPV2 Is a Component of Osmotically Sensitive Cation Channels in Murine Aortic Myocytes. Circulation Research. 93(9). 829–838. 391 indexed citations
17.
Satō, Atsushi, et al.. (2002). [Chemotherapy of gastric cancer--a review of clinical trials in Japan].. PubMed. 29(9). 1522–31. 1 indexed citations
18.
Taniguchi, Yukio, Tomohiro Ito, Takahisa Yamada, & Yoshiyuki Sasaki. (2002). Genomic Structure and Promoter Analysis of the Bovine Leptin Gene. IUBMB Life. 53(2). 131–135. 40 indexed citations
19.
Ito, Tomohiro, Kazuhiro Kaneko, Reiko Makino, et al.. (2001). Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. Journal of Gastroenterology. 36(5). 303–311. 27 indexed citations
20.
Ishii, Shinya, et al.. (2000). [Role of national insurance pharmacies in community complete home care networks--home TPN and home care supported by local national insurance pharmacies].. PubMed. 27 Suppl 3. 683–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Mark Duffy Breakdown of academic impact, for papers by Sarabeth Graham Breakdown of academic impact, for papers by Cheng–Hai Zhang Breakdown of academic impact, for papers by Catalin N. Topala Breakdown of academic impact, for papers by Subhashini Srivatsan Breakdown of academic impact, for papers by Judd W. Landsberg Breakdown of academic impact, for papers by Chee Gee See Breakdown of academic impact, for papers by April Hawkins Breakdown of academic impact, for papers by Michael Song Breakdown of academic impact, for papers by Otor Al‐Khalili
Rankless by CCL
2026